Point-of-Care Testing (POCT) Devices for DNA Detection: A Comprehensive Review

IF 4 Q2 ENGINEERING, BIOMEDICAL

Advanced Nanobiomed Research Pub Date : 2023-11-20 DOI:10.1002/anbr.202370111

Ignasia Handipta Mahardika, Sarida Naorungroj, Wisarut Khamcharoen, Sarath Kin, Nadnudda Rodthongkum, Orawon Chailapakul, Kwanwoo Shin

引用次数: 0

Abstract

DNA Detection

DNA chips have transformed point-of-care diagnostics, offering rapid, precise genetic data detection. Integrated into lab-on-a-chip setups, they facilitate cost-effective, portable testing. In article number 2300058, Nadnudda Rodthongkum, Orawon Chailapakul, Kwanwoo Shin, and co-workers discuss recent rapid diagnostic DNA chip platforms, probe selection, and detection methods, emphasizing their potential to enhance patient outcomes and disease management.

Abstract Image

查看原文本刊更多论文

用于DNA检测的即时检测(POCT)设备:全面综述

DNA检测DNA芯片已经改变了即时诊断，提供快速、精确的基因数据检测。集成到芯片实验室设置中，它们促进了成本效益高的便携式测试。在2300058号文章中，Nadnudda Rodthongkum、Orawon Chailapakul、Kwanwoo Shin及其同事讨论了最近的快速诊断DNA芯片平台、探针选择和检测方法，强调了它们提高患者预后和疾病管理的潜力。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Advanced Nanobiomed Research nanomedicine, bioengineering and biomaterials-

CiteScore

5.00

自引率

5.90%

发文量

审稿时长

21 weeks

期刊介绍： Advanced NanoBiomed Research will provide an Open Access home for cutting-edge nanomedicine, bioengineering and biomaterials research aimed at improving human health. The journal will capture a broad spectrum of research from increasingly multi- and interdisciplinary fields of the traditional areas of biomedicine, bioengineering and health-related materials science as well as precision and personalized medicine, drug delivery, and artificial intelligence-driven health science. The scope of Advanced NanoBiomed Research will cover the following key subject areas: ▪ Nanomedicine and nanotechnology, with applications in drug and gene delivery, diagnostics, theranostics, photothermal and photodynamic therapy and multimodal imaging. ▪ Biomaterials, including hydrogels, 2D materials, biopolymers, composites, biodegradable materials, biohybrids and biomimetics (such as artificial cells, exosomes and extracellular vesicles), as well as all organic and inorganic materials for biomedical applications. ▪ Biointerfaces, such as anti-microbial surfaces and coatings, as well as interfaces for cellular engineering, immunoengineering and 3D cell culture. ▪ Biofabrication including (bio)inks and technologies, towards generation of functional tissues and organs. ▪ Tissue engineering and regenerative medicine, including scaffolds and scaffold-free approaches, for bone, ligament, muscle, skin, neural, cardiac tissue engineering and tissue vascularization. ▪ Devices for healthcare applications, disease modelling and treatment, such as diagnostics, lab-on-a-chip, organs-on-a-chip, bioMEMS, bioelectronics, wearables, actuators, soft robotics, and intelligent drug delivery systems. with a strong focus on applications of these fields, from bench-to-bedside, for treatment of all diseases and disorders, such as infectious, autoimmune, cardiovascular and metabolic diseases, neurological disorders and cancer; including pharmacology and toxicology studies.